HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: ifrs:ComprehensiveIncomeAttributableToOwnersOfParent
| Value | {"amount": 88000000.0} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:19:57.341023+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/3863295d-1cfd-4448-a14f-bac150b3871b
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300BNS685UXH4JI75:2023-12-31Retrieved: 2026-08-24T00:19:57.341023+02:00
Raw response sha256:
405afb5c38619133da701aca0c644ab8…Cite as: FACTANKER, https://factanker.com/fact/3863295d-1cfd-4448-a14f-bac150b3871b
History
- no predecessors — first report